Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combination With Chemotherapy in Metastatic Nasopharyngeal Carcinoma
NCT01612286Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- May 2012
- Primary completion
- Dec 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01612286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612286.